Formula Grant 2601GAPADD
- The Georgia Advocacy Office, Inc. was awarded a $2.15 million Formula Grant from the U.S. Department of Health and Human Services Administration for Community Living under the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630) for the period of October 1, 2021 through September 30, 2023. The grant aims to enable individuals with developmental disabilities to become independent, productive, integrated and included into their communities by providing advocacy,...
- The Georgia Advocacy Office, Inc. was awarded a $228,000 Block Grant from the Department of Health and Human Services Administration for Community Living on March 1, 2022 to support services through September 30, 2024. The funding is provided through the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630) to enable individuals with developmental disabilities to become independent, productive, integrated and included into their communities. As the sub-awardee,...
- This FY2026 Formula Grant award of $750,180 is provided by the U.S. Department of Health and Human Services Administration for Community Living under the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630). The grant supports the Georgia Department of Behavioral Health and Developmental Disabilities (DBHDD) in developing and implementing a comprehensive system of services and supports to enable individuals with developmental disabilities to achieve independence,...
- The Georgia Advocacy Office, Inc. received a $314,778 Formula Grant award from the Department of Health and Human Services Administration for Community Living under the Voting Access for Individuals with Disabilities-Grants for Protection and Advocacy Systems program (CFDA 93.618). The award period is from October 1, 2021 through September 30, 2026. Under this award, the Georgia Advocacy Office, Inc. will provide services to ensure full participation in the electoral process for individuals with...
- The Georgia Advocacy Office, Inc. was awarded a $269,374 Formula Grant from the U.S. Department of Health and Human Services Administration for Community Living under the ACL Assistive Technology State Grants for Protection and Advocacy program (CFDA #93.843). The grant period is from October 1, 2021 through September 30, 2023. Under this award, the Georgia Advocacy Office will provide protection and advocacy services to assist individuals with disabilities in acquiring and utilizing assistive...
- The Georgia Advocacy Office, Inc. received a $212,592 Formula Grant award from the Department of Health and Human Services Administration for Community Living on October 1, 2021 to provide services through September 30, 2023. The grant was awarded under the State Grants for Protection and Advocacy Services program (CFDA 93.873) to enable Protection and Advocacy systems in each state to assist individuals with traumatic brain injury. Services provided include information and referrals, advice,...
- The Department of Health and Human Services Administration for Community Living has awarded a $733,441 Formula Grant under the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630) to Disability Advocates Inc., doing business as Disability Rights New York. This two-year grant, with an award date of October 1, 2025 and an ultimate completion date of September 30, 2027, supports the organization's work to enable individuals with developmental disabilities in New York...
- The Developmental Disabilities Basic Support and Advocacy Grants program, administered by the U.S. Department of Health and Human Services Administration for Community Living (CFDA 93.630), awarded Disability Rights Ohio a $448,955 Formula Grant to provide comprehensive legal and policy advocacy services that support independence, productivity, and community integration for individuals with developmental disabilities in the state of Ohio. The grant, which runs from October 1, 2025 to September...
- This $141,690 federal formula grant award from the Administration on Disabilities (under the U.S. Department of Health and Human Services) supports the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630). The award recipient, Disability Rights Mississippi, is the designated state protection and advocacy system for individuals with disabilities in Mississippi. This two-year grant, running from October 1, 2025 to September 30, 2027, enables Disability Rights...
- This $389,533 formula grant award from the U.S. Department of Health and Human Services' Administration for Community Living supports the Developmental Disabilities Basic Support and Advocacy Grants program (CFDA 93.630). The grant recipient, Disability Rights North Carolina, is the designated Protection and Advocacy (P&A) system for the state. Through this funding, Disability Rights North Carolina will provide legal advocacy, information dissemination, systemic investigations, and direct...
The U.S. Department of Health and Human Services Administration for Community Living awarded a $389,279 Developmental Disabilities Basic Support and Advocacy Grants (CFDA 93.630) formula grant to the Georgia Advocacy Office, Inc. for the period of October 1, 2025 to September 30, 2027. This grant enables the Georgia Advocacy Office, a non-profit organization, to develop and implement a comprehensive system of support services that promote independence, productivity, and community integration for individuals with developmental disabilities in the state of Georgia. The grant funds will be used to provide a range of advocacy, legal support, and rights protection services, including investigating rights violations, ensuring voting access, facilitating assistive technology support, and educating individuals about their rights. These services are designed to help individuals with developmental disabilities achieve greater independence and full participation in their communities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $389.3k | 12/15/25 |